Bibliografía del artículo
1. Chwalisz K, Garfield E. Role of nitric oxide in the uterus and cervix: Implications for the management of labor. J Perinat Med 26:448-457, 1998.
2. Bullarbo M, Orrskog ME, Andersch B, Granström L, Norström A, Ekerhovd E. Outpatient vaginal administration of the nitric oxide donor isosorbide mononitrate for cervical ripening and labor induction postterm: a randomized controlled study. Am J Obstet Gynecol 196(1):50.e1-5, 2007.
3. Ekerhovd E, Bullarbo M, Andersch B, Norström A. vaginal administration of the nitric oxide donor isosorbide mononitrate for cervical ripening at term: A randomized controlled study. Am J Obstet Gynecol 189:1692-1697, 2003.
4. Thomson AJ, Lunan CB, Ledingham M et al. Randomised trial of nitric oxide donor versus prostaglandin for cervical ripening before first-trimester termination of pregnancy. Lancet 352:1093-1096, 1998.
5. Chanrachakul B, Herabutya Y, Punyavachira P. Randomized comparison of glyceryl trinitrate and prostaglandine E2 for cervical ripening at term. Obstet Gynecol 96:549-553, 2000.
6. Sharma Y, Kumar S, Mittal S, Misra R, Dadhwal V. Evaluation of glyceryl trinitrate, misoprostol, and prostaglandin E2 gel for preinduktion cervical ripening in term pregnancy. J Obstet Gynecol Res 31:210-215, 2005.
7. David M, Chen F, Lichtenegger W. NO-donor nitroglycerin versus the prostaglandin gemeprost for cervical ripening in first trimester missed abortion. Int J Gynaecol Obstet 83:71-2, 2003.
8. Bugalho A Bique C, Almeida L, Bergstrom S. Application of vaginal misoprostol before cervical dilatation to facilitate first-trimester pregnancy interruption. Obstet Gynecol 83:729-31, 1994.
9. Elsheikh A, Antsaklis A, Mesogitis S, Papantoniou N, Rodolakis A, Vogas E, Michalas S. Use of misoprostol for the termination of second trimester pregnancies. Arch Gynecol Obstet 265:204-6, 2001.
10. Esteve JL, Varela L, Velazco A, Tanda R, Cabezas E, Sanchez C. Early abortion with 800 micrograms of misoprostol by the vaginal route. Contraception 59:219-25, 1999.
11. David M, Chen F. Comparison of isosorbide mononitrate (Mono Mack) and misoprostol (Cytotec) for cervical ripening in the first trimester missed abortion. Arch Gynecol Obstet 6:1-2, 2005.
12. Aronsson A, Fiala C, Stephansson O et al. Pharmacokinetic profiles up to 12 h after administration of vaginal, sublingual and slow-release oral misoprostol. Hum Reprod 22:1912-8, 2007.
13. Bartusevicius A, Barcaite E, Krikstolaitis R, Gintautas V, Nadisauskiene R. Sublingual compared with vaginal misoprostol for labour induction at term: a randomised controlled trial. BJOG 113:1431-7, 2006.
14. Carbonell Esteve JL, Marí JM, Valero F et al. Sublingual versus vaginal misoprostol (400 microg) for cervical priming in first-trimester abortion: a randomized trial. Contraception 74:328-33, 2006.
15. Von Hertzen H, Piaggio G, Huong NT et al; WHO Research Group on Postovulatory Methods of Fertility Regulation. Efficacy of two intervals and two routes of administration of misoprostol for termination of early pregnancy: a randomised controlled equivalence trial. Lancet 369(9577):1938-46, 2007.
16. Chen FCK, Bergann A, Krosse J, Merholz A, David M. Isosorbide mononitrate vaginal gel versus misoprostol vaginal gel versus Dilapan S® for cervical ripening before first trimester curettage. Eur J Obstet Gynecol Reprod Biol 2007, in press.
17. Kline SB, Meng H, Munsick RA. Cervical dilation from laminara tents and synthetic osmotic dilators used for 6 hours before abortion. Obstet Gynecol 86:931-5, 1999.